US Stock MarketDetailed Quotes

Arrowhead Pharmaceuticals (ARWR)

Watchlist
  • 69.590
  • +1.990+2.94%
Close Jan 22 16:00 ET
9.70BMarket Cap-6959.00P/E (TTM)

Arrowhead Pharmaceuticals (ARWR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q4)Sep 30, 2025
(Q3)Jun 30, 2025
(Q2)Mar 31, 2025
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
138.79%179.55M
114.93%20.49M
-34.05%-154.72M
598.02%460.05M
-24.13%-146.27M
-200.77%-462.85M
-429.26%-137.22M
-455.51%-115.42M
-191.68%-92.38M
-56.05%-117.84M
Net income from continuing operations
104.94%30.11M
109.30%16.12M
-2.69%-178.65M
389.67%367.86M
-29.43%-175.22M
-191.34%-609.69M
-56.14%-173.34M
-67.08%-173.98M
-366.37%-127M
-223.78%-135.38M
Operating gains losses
-4,091.25%-3.19M
----
----
----
----
--80K
--160K
--0
--0
---80K
Depreciation and amortization
28.68%23.93M
27.08%6.39M
30.13%6.22M
34.45%6.08M
22.80%5.24M
48.84%18.6M
30.22%5.03M
45.97%4.78M
69.54%4.53M
58.53%4.26M
Other non cash items
176.21%89.36M
48.11%21.69M
378.76%24.38M
198.66%21.64M
303.32%21.65M
76.54%32.35M
178.35%14.65M
-1.26%5.09M
43.27%7.25M
88.38%5.37M
Change In working capital
-172.68%-18.24M
-582.39%-38.36M
-172.88%-17.96M
1,251.69%45.53M
31.57%-7.44M
148.68%25.09M
-86.47%7.95M
-55.93%24.64M
103.15%3.37M
81.67%-10.87M
-Change in receivables
---56.97M
---47.13M
---7.48M
--135K
---2.5M
--0
--0
--0
--0
--0
-Change in prepaid assets
-497.30%-9.94M
15,025.61%12.4M
-256.74%-1.41M
-2,173.07%-20.34M
66.13%-592K
-114.34%-1.66M
100.50%82K
-88.20%897K
-109.15%-895K
-116.60%-1.75M
-Change in payables and accrued expense
79.76%47.78M
69.61%18.17M
-48.88%12.41M
499.29%21.83M
61.66%-4.62M
47.40%26.58M
-76.26%10.71M
474.18%24.28M
132.18%3.64M
-29.97%-12.06M
-Change in other current liabilities
-305.58%-4.61M
27.56%-1.19M
----
-281.48%-1.13M
-129.72%-1.13M
-95.19%2.24M
-103.66%-1.64M
---537K
--621K
579.07%3.8M
-Change in other working capital
365.88%5.49M
-1,617.83%-20.61M
-309.21%-18.08M
868.53%42.78M
261.89%1.4M
98.40%-2.07M
92.52%-1.2M
70.97%-4.42M
105.89%4.42M
96.23%-866K
Cash from discontinued investing activities
Operating cash flow
138.79%179.55M
114.93%20.49M
-34.05%-154.72M
598.02%460.05M
-24.13%-146.27M
-200.77%-462.85M
-429.26%-137.22M
-455.51%-115.42M
-191.68%-92.38M
-56.05%-117.84M
Investing cash flow
Cash flow from continuing investing activities
69.22%-129.29M
132.58%72.62M
1,934.68%141.39M
-56.25%-420.21M
18.62%76.91M
-336.87%-420.07M
-830.68%-222.92M
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
Net PPE purchase and sale
83.98%-22.67M
69.17%-7.49M
83.64%-2.36M
84.45%-5.3M
89.05%-7.52M
19.96%-141.47M
61.99%-24.29M
69.00%-14.45M
-24.75%-34.08M
-76.44%-68.66M
Net investment purchase and sale
61.73%-106.63M
140.33%80.11M
571.81%143.75M
-76.66%-414.92M
-36.76%84.43M
-445.74%-278.6M
-310.38%-198.63M
-41.69%21.4M
-2,583.83%-234.86M
419.50%133.5M
Cash from discontinued investing activities
Investing cash flow
69.22%-129.29M
132.58%72.62M
1,934.68%141.39M
-56.25%-420.21M
18.62%76.91M
-336.87%-420.07M
-830.68%-222.92M
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
Financing cash flow
Cash flow from continuing financing activities
-91.50%74.01M
-99.06%3.67M
-184.70%-42.68M
-78.55%92.38M
7,628.09%20.63M
244.01%870.52M
47,292.08%389.09M
4,335.48%50.39M
82,741.73%430.78M
-99.89%267K
Net issuance payments of debt
-148.82%-191.37M
-97.38%10.26M
---50M
----
----
--392M
--392M
--0
----
----
Net common stock issuance
-43.77%241.39M
--0
--0
----
----
--429.27M
--0
--0
----
----
Proceeds from stock option exercised by employees
1,113.19%28.98M
127.35%507K
-42.38%223K
73.21%2.62M
9,500.75%25.63M
-21.75%2.39M
-72.84%223K
-65.93%387K
190.77%1.51M
-53.65%267K
Net other financing activities
-110.67%-5M
-126.48%-7.1M
--7.1M
--0
---5M
-81.25%46.87M
---3.13M
----
----
----
Cash from discontinued financing activities
Financing cash flow
-91.50%74.01M
-99.06%3.67M
-184.70%-42.68M
-78.55%92.38M
7,628.09%20.63M
244.01%870.52M
47,292.08%389.09M
4,335.48%50.39M
82,741.73%430.78M
-99.89%267K
Net cash flow
Beginning cash position
-7.40%102.69M
87.02%129.79M
45.42%185.71M
-7.43%53.89M
-7.40%102.69M
2.67%110.89M
-34.12%69.4M
-5.38%127.7M
-71.22%58.22M
2.67%110.89M
Current changes in cash
1,101.89%124.26M
234.30%96.78M
3.57%-56.01M
90.35%132.22M
7.60%-48.73M
-512.33%-12.4M
435.71%28.95M
-96.58%-58.08M
203.34%69.46M
-155.88%-52.73M
Effect of exchange rate changes
-109.55%-401K
-100.55%-24K
141.70%93K
-1,646.15%-402K
-217.24%-68K
3,540.16%4.2M
2,733.99%4.34M
-182.28%-223K
135.14%26K
147.54%58K
End cash Position
120.62%226.55M
120.62%226.55M
87.02%129.79M
45.42%185.71M
-7.43%53.89M
-7.40%102.69M
-7.40%102.69M
-34.12%69.4M
-5.38%127.7M
-71.22%58.22M
Free cash flow
125.96%156.89M
108.05%13M
-20.96%-157.08M
459.63%454.76M
17.54%-153.79M
-82.78%-604.32M
-79.78%-161.51M
-92.73%-129.87M
-114.38%-126.45M
-62.98%-186.5M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Sep 30, 2025(Q4)Sep 30, 2025(Q3)Jun 30, 2025(Q2)Mar 31, 2025(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 138.79%179.55M114.93%20.49M-34.05%-154.72M598.02%460.05M-24.13%-146.27M-200.77%-462.85M-429.26%-137.22M-455.51%-115.42M-191.68%-92.38M-56.05%-117.84M
Net income from continuing operations 104.94%30.11M109.30%16.12M-2.69%-178.65M389.67%367.86M-29.43%-175.22M-191.34%-609.69M-56.14%-173.34M-67.08%-173.98M-366.37%-127M-223.78%-135.38M
Operating gains losses -4,091.25%-3.19M------------------80K--160K--0--0---80K
Depreciation and amortization 28.68%23.93M27.08%6.39M30.13%6.22M34.45%6.08M22.80%5.24M48.84%18.6M30.22%5.03M45.97%4.78M69.54%4.53M58.53%4.26M
Other non cash items 176.21%89.36M48.11%21.69M378.76%24.38M198.66%21.64M303.32%21.65M76.54%32.35M178.35%14.65M-1.26%5.09M43.27%7.25M88.38%5.37M
Change In working capital -172.68%-18.24M-582.39%-38.36M-172.88%-17.96M1,251.69%45.53M31.57%-7.44M148.68%25.09M-86.47%7.95M-55.93%24.64M103.15%3.37M81.67%-10.87M
-Change in receivables ---56.97M---47.13M---7.48M--135K---2.5M--0--0--0--0--0
-Change in prepaid assets -497.30%-9.94M15,025.61%12.4M-256.74%-1.41M-2,173.07%-20.34M66.13%-592K-114.34%-1.66M100.50%82K-88.20%897K-109.15%-895K-116.60%-1.75M
-Change in payables and accrued expense 79.76%47.78M69.61%18.17M-48.88%12.41M499.29%21.83M61.66%-4.62M47.40%26.58M-76.26%10.71M474.18%24.28M132.18%3.64M-29.97%-12.06M
-Change in other current liabilities -305.58%-4.61M27.56%-1.19M-----281.48%-1.13M-129.72%-1.13M-95.19%2.24M-103.66%-1.64M---537K--621K579.07%3.8M
-Change in other working capital 365.88%5.49M-1,617.83%-20.61M-309.21%-18.08M868.53%42.78M261.89%1.4M98.40%-2.07M92.52%-1.2M70.97%-4.42M105.89%4.42M96.23%-866K
Cash from discontinued investing activities
Operating cash flow 138.79%179.55M114.93%20.49M-34.05%-154.72M598.02%460.05M-24.13%-146.27M-200.77%-462.85M-429.26%-137.22M-455.51%-115.42M-191.68%-92.38M-56.05%-117.84M
Investing cash flow
Cash flow from continuing investing activities 69.22%-129.29M132.58%72.62M1,934.68%141.39M-56.25%-420.21M18.62%76.91M-336.87%-420.07M-830.68%-222.92M170.16%6.95M-645.70%-268.94M180.35%64.84M
Net PPE purchase and sale 83.98%-22.67M69.17%-7.49M83.64%-2.36M84.45%-5.3M89.05%-7.52M19.96%-141.47M61.99%-24.29M69.00%-14.45M-24.75%-34.08M-76.44%-68.66M
Net investment purchase and sale 61.73%-106.63M140.33%80.11M571.81%143.75M-76.66%-414.92M-36.76%84.43M-445.74%-278.6M-310.38%-198.63M-41.69%21.4M-2,583.83%-234.86M419.50%133.5M
Cash from discontinued investing activities
Investing cash flow 69.22%-129.29M132.58%72.62M1,934.68%141.39M-56.25%-420.21M18.62%76.91M-336.87%-420.07M-830.68%-222.92M170.16%6.95M-645.70%-268.94M180.35%64.84M
Financing cash flow
Cash flow from continuing financing activities -91.50%74.01M-99.06%3.67M-184.70%-42.68M-78.55%92.38M7,628.09%20.63M244.01%870.52M47,292.08%389.09M4,335.48%50.39M82,741.73%430.78M-99.89%267K
Net issuance payments of debt -148.82%-191.37M-97.38%10.26M---50M----------392M--392M--0--------
Net common stock issuance -43.77%241.39M--0--0----------429.27M--0--0--------
Proceeds from stock option exercised by employees 1,113.19%28.98M127.35%507K-42.38%223K73.21%2.62M9,500.75%25.63M-21.75%2.39M-72.84%223K-65.93%387K190.77%1.51M-53.65%267K
Net other financing activities -110.67%-5M-126.48%-7.1M--7.1M--0---5M-81.25%46.87M---3.13M------------
Cash from discontinued financing activities
Financing cash flow -91.50%74.01M-99.06%3.67M-184.70%-42.68M-78.55%92.38M7,628.09%20.63M244.01%870.52M47,292.08%389.09M4,335.48%50.39M82,741.73%430.78M-99.89%267K
Net cash flow
Beginning cash position -7.40%102.69M87.02%129.79M45.42%185.71M-7.43%53.89M-7.40%102.69M2.67%110.89M-34.12%69.4M-5.38%127.7M-71.22%58.22M2.67%110.89M
Current changes in cash 1,101.89%124.26M234.30%96.78M3.57%-56.01M90.35%132.22M7.60%-48.73M-512.33%-12.4M435.71%28.95M-96.58%-58.08M203.34%69.46M-155.88%-52.73M
Effect of exchange rate changes -109.55%-401K-100.55%-24K141.70%93K-1,646.15%-402K-217.24%-68K3,540.16%4.2M2,733.99%4.34M-182.28%-223K135.14%26K147.54%58K
End cash Position 120.62%226.55M120.62%226.55M87.02%129.79M45.42%185.71M-7.43%53.89M-7.40%102.69M-7.40%102.69M-34.12%69.4M-5.38%127.7M-71.22%58.22M
Free cash flow 125.96%156.89M108.05%13M-20.96%-157.08M459.63%454.76M17.54%-153.79M-82.78%-604.32M-79.78%-161.51M-92.73%-129.87M-114.38%-126.45M-62.98%-186.5M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More